Molecular level studies on platelets deficient in collagen-induced aggregation provide evidence for identifying possible platelet collagen receptors. We investigated platelets from a patient with mild bleeding time prolongation, but otherwise normal coagulation data. Her platelets lacked collagen-induced aggregation and adhesion, but retained normal aggregation and release by other agonists. Labeling her platelets with 125I or 3H and analysis by SDS-PAGE/autoradiography showed normal levels of glycoproteins Ia, Ib, Ila, IIb, IIIa, and IV. However, there were significantly decreased incorporations of both radioactivities into a 61-kD membrane glycoprotein (GP), which was identified as GPVI from its mobility on unreduced-reduced, two-dimensional SDS-PAGE. Sugiyama et al. ( . Blood. 69: 1712 reported that the serum from an idiopathic thrombocytopenic purpura (ITP) patient contained an antibody against a 62-kD platelet protein. Our patient's platelets lacked the antigen for the ITP patient's antibody, demonstrating that the ITP serum contains a specific antibody against GPVI. The patient's parents' platelets contained -50% the normal amount of GPVI, but still had normal collagen-induced aggregation and adhesion. The patient's platelets did not bind to types I and III collagen fibrils. Our results suggest that GPVI functions as a collagen receptor.
Introduction
Because the adhesion of platelets to subendothelial components is the first reaction ofthrombus formation and one ofthe subendothelial components that reacts with platelets is collagen, the specific interaction of platelets with collagen is a crucial yet elusive topic of investigation for numerous platelet researchers. Many platelet proteins have been proposed to be components that interact with collagen on the cell surface. Collagen:glucosyl transferase (1), fibronectin (2) , glycoprotein (GP)' lIb (3), 65-kD protein (4), 61-kD protein (5) , Factor XIII (6) , and thrombospondin (7, 8) were proposed to be platelet receptors for collagen, but none were confirmed to be such. Recently GPIa was identified as a receptor for collagen from studies using GPIa-deficient platelets (9) and MAb against GPIa (10) . In this context, a patient whose platelets have no collagen-induced aggregation and adhesion, and who shows a deficiency of a specific protein, would provide strong evidence that this protein is a collagen receptor. Previously we presented a case report on a patient whose platelets specifically lacked collagen-induced aggregation and were unable to adhere to collagen fibrils (1 1) . In this report we analyzed the membrane GPs of this patient's platelets and showed that her platelets lacked a 6 l-kD GP, which we identified as GPVI ofthe platelet membrane. These results indicate that GPVI is involved in the interaction between platelets and collagen.
Methods
Case history. The patient was a 26-yr-old woman in 1985 when she first came to our hospital to undergo a blood examination because of purpura on her body. She had an ongoing tendency to develop purpura since she was a young child, occasionally had hypermennorrhea, and sometimes required several hours to stop a nosebleed. However, she never had any severe bleeding problems.
Coagulation studies showed that the patient had normal levels ofall coagulation factors, a normal prothrombin time, and a normal activated partial thromboplastin time. The Factor VIII activity and the activity ofvWf(measured by antigenic activity and ristocetin cofactor) were normal. Her bleeding time was slightly prolonged (8.5 min as compared with 2-6 min for normal individuals). The clinical data for her platelet activity are summarized in Table I . The only platelet abnormality was inability to adhere to collagen fibrils and lack of collagen-induced aggregation. Aggregations by other agents and the release reaction were all normal.
The patient was not the child of a consanguineous marriage, and her parents showed normal values for the tests in which the patient exhibited abnormalities.
Platelet preparations. Whole blood was drawn from the antecubital vein of the patient, the parents of the patient, and healthy volunteers into 0.1 vol of 3.8% sodium citrate. The whole blood was centrifuged at 700 g for 5.5 min, and the resultant platelet-rich plasma (PRP) was used for the following analyses.
For platelet GP analysis, the PRP was added to 0.1 vol of 0.5 M EDTA solution, pH 7.4, and then sedimented by centrifugation at 1,000 g for 10 min. The resultant pellet was washed twice with buffer A, which consisted of 6.85 mM citrate, 130 mM NaCl, 4 mM KCI, 5.5 mM glucose, and 5 mM EDTA, pH adjusted to 6.5. The washed platelets were dissolved by adding a solution of 2% SDS, 8 M urea, and 10 mM N-ethylmaleimide (NEM), followed by heating at 85'C for 5 min.
Platelet aggregation and the release reaction were monitored by a lumiaggregometer (Chrono-Log Corp., Havertown, PA). 0.45 ml PRP was mixed with 50 ul luciferase-luciferin reagent (Chrono-Log Corp.) and the stimulants were added. For some assays the luciferase-luciferin reagent was omitted and only the aggregation reaction was monitored. (Sigma Chemical Co.) . After washing twice with buffer A the platelets were dissolved in SDS/urea/NEM solution as described above. Platelets were also tritium-labeled by the periodate method of Berndt and Phillips (13) . After washing with 1 mM EDTA, 0.15 M NaCl, and 10 mM Hepes, pH 7.6, the labeled platelets were dissolved in SDS/urea/NEM solution. The solubilized platelets were analyzed by two-dimensional gel electrophoresis (described in the next section), and the gel was dried in the presence or absence of EN3HANCE (New England Nuclear, Boston, MA) for the detection of 'H or 125i, respectively, and exposed to Fuji x-ray film (Fuji Photo Film Co., Ltd., Kanagawa, Japan) for 1 wk at -700C.
Gel electrophoresis and related techniques. The Laemmli method (14) was used for SDS-PAGE. Two-dimensional, unreduced-reduced gel electrophoresis was performed as described previously (15, 16) . The electrophoresed gels were also electrophoretically transferred to nitrocellulose membranes (BA85; Schleicher & Schuell, Inc., Keene, NH) (17) and stained with antibody. The transferred and washed nitrocellulose strips were reacted with serum from the idiopathic thrombocytopenic purpura (ITP) patient described by Sugiyama et al. (18) , which was diluted 100-fold with 10 mM Tris, 0.14 M NaCl, and 0.5% BSA, pH 7.4, washed, incubated with peroxidase-conjugated antihuman IgG antibody (0.5 gg/ml; E. Y. Laboratories, Inc., San Mateo, CA), and finally reacted with 0.02% 3,3'-diamino-benzidine and 0.005% H202 to visualize the proteins.
The amounts of GPVI were measured by densitometry ofthe antibody-stained nitrocellulose paper (19) . On the same gel, different amounts of whole platelet proteins from a normal individual (chosen as the standard, reference sample) and 2-,Ag samples of whole platelet proteins from the patient, her parents, and other controls (normal volunteers) were analyzed by SDS-PAGE/immunostaining with ITP serum as described above; the amounts of GPVI were determined by densitometry, measuring the GPVI peak in terms of arbitrary units of area. A standard curve was made by plotting the areas obtained for different amounts of the reference sample against the amount of applied reference sample. The relative amounts of GPVI in the samples from the patient, her parents, and controls were calculated from their respective GPVI peak areas and the standard curve and expressed as a percentage of the reference sample.
Adhesion ofplatelets to collagens. Adhesion of platelets to collagen was measured by the method described by Mant (20) . PRP was separated as described above and mixed with autologous platelet-poor plasma so that the platelet count was 2.5 X 108/ml, and then a sufficient amount of 0. The patient's platelets were also labeled with 125I and analyzed by unreduced-reduced, two-dimensional SDS-PAGE (Fig. 3) . The amounts of GPIa, GPIb, GPIIa, GPIIb, GPIIIa, and GPIV in the patient's platelets were similar to those of normal platelets. However, a spot with a molecular mass of 60 kD (as indicated by the star in Fig. 3 ) is nonexistent or extraordinarily faint in the patient's platelets. The molecular mass of this GP, which was designated as GPVI according to the definition by Phillips (22) Fig. 4 , a main band with a molecular mass of 61 kD was stained in the normal platelets. However, the patient's platelets lacked this band, which indicated that the antibody ofthe ITP patient was the patient's an antibody against GPVI, and the platelets of her parents )P, epineph-showed a decrease in the contents of GPVI. Staining also derombin, but tected a 260-kD protein; this band can be ascribed to the Fc aggregation. receptor ofthe platelet membrane (23) because normal human also demon-plasma also stained the same band, and the band was not 7P normally. stained when the sample was reduced (data not shown). How Fig. 4 A. These bands may be stained because the plasma from the ITP patient that we used for the staining might contain small amounts of antibodies against some other platelet proteins. The amounts of GPVI were semi-quantitated with densitometry (Fig. 4 B) . The GPVI contents in the platelets from the patient's father and mother were calculated to be 51. 4 Adhesion of the patient's platelets to collagen fibrils. The ability ofthe patient's platelets to adhere to collagen fibrils was examined using several types of purified collagens. Table II shows that normal platelets adhere to bovine type III and human types I and III, but the patient's platelets fail to adhere to any ofthem. Other types ofcollagen, bovine types I, IV, and V, did not show significant binding to either the normal platelets or those from our patient. This may be because these collagen preparations must be present at higher concentrations to bind a significant number of platelets in our assay system, since substantially higher concentrations of these collagens were required to induce platelet aggregation relative to the required amounts ofbovine type III and human types I and III collagens. Table I shows the adhesion data that were obtained by the same method but with the use of horse tendon collagen, which is mainly composed of type I collagen. Again, the patient's platelets showed a lack ofadhesion to these collagen fibrils and the platelets from her parents adhered normally. The aggregation studies ( Fig. 1 and Table I ) indicated that the platelets from our patient specifically lacked reactivity towards collagen. The patient's platelets aggregate normally in response to ADP and AA, indicating that their aggregability and release reaction were normal. Although the ATP release in Fig. 1 shows that the patient's platelets released less ATP than the platelets from the particular normal individual used in this study, the data from the quantitative investigation given in Table I show that the release reaction of the patient's platelets were well within the normal range of levels (1 1). The patient's platelets did not show any aggregation in response to collagen at concentrations up to 10 Ag/ml. However, they apparently reacted with collagen, because a slight increase in transmission was observed. This transmission increase was dose dependent, ranging from 3 to 12% of light transmission (1 1). Part of this transmission increase could be ascribed to the polymerization of collagen. Platelets from the ITP patient with an autoantibody against GPVI (18) also showed a slight reactivity towards collagen; this was different from the behavior of the platelets from the GPIa-deficient patient who had defective collageninduced aggregation (9) .
From the radiolabeling studies of normal platelets and those from the patient, the patient's platelets were found to have a very profound decrease or absence of a 61 -kD GP. The patient's platelets also showed markedly decreased binding towards collagen fibrils. Several other groups have suggested a GP with a similar molecular weight to be a receptor for collagen. Chiang and Kang purified a protein with a molecular mass of 65 kD from human platelet membranes using an affinity column of immobilized chicken alpha 1 -(I) collagen (4). Kotite and Cunningham identified a platelet membrane GP with a molecular mass of 61 kD that bound specifically to insoluble collagen fibrils (5). Furthermore, Sugiyama et al. (18) reported a patient with ITP whose platelets had a defect in collagen-induced aggregation. The patient's serum contained an antibody that recognized a platelet membrane protein with a molecular mass of 62 kD (18) . A very interesting finding of the present study was the identification of GPVI, which was absent in our patient's platelets, as one of the candidates for these collagen receptors. Immunoblotting analysis using serum from the ITP patient described by Sugiyama et al. (18) as the first antibody showed that the patient's platelets also lacked the antigen that the ITP patient's antibody recognizes (Fig. 4) . The identity of GPVI and the antigen of the ITP patient's antibody was also indicated from our aggregation studies (Fig. 5) . These data indicated that the antibody from the ITP patient was an antibody against GPVI. Our data combined with the data on the ITP patient (18) strongly suggested that GPVI takes part in the interaction of platelets with collagen, and it may be one of the collagen receptors on the platelet membrane. The other proteins reported to be collagen receptors (4, 5) Semi-quantitative analysis of the GPVI contents in the platelets from the patient's parents showed that both her parents had about half the amount of GPVI in comparison with normal platelets, which indicates that the patient's GPVI defect is inherited from both parents. However, the parents' platelets showed normal aggregability against collagen and normal adhesion to collagen fibrils. This would be because 50% GPVI is sufficient for platelets to interact with collagen fibrils.
When the aggregation profiles of the GPIa-deficient patient described by Nieuwehuis et al. (9) were compared with those of our patient, the former patient showed absolutely no reactivity to collagen, but our patient showed a very small extent of platelet aggregation under the usual conditions used for the aggregation test. Also, the GPIa-deficient individual had a more severe bleeding tendency, having a longer prolongation of bleeding time in comparison with our GPVI-deficient patient who showed only a mild bleeding tendency. These results suggest that GPIa would play a more significant role on the platelet surface during hemostasis than GPVI. However, the mechanism of the interaction between platelets and collagen that is a component of the subendothelium is still not fully understood because collagen has a macromolecular structure and would therefore be expected to interact with many proteins. The GPVI-deficient platelets described in this study would be a useful means to study the interaction between platelets and collagen.
